[Multidisciplinary treatment of lung cancer].
In our hospital 94 patients with small cell lung cancer were admitted the past 10 years. 21 patient have undergone surgical resection following the chemotherapy with VEMT regimen. The 5 year survival rate of the patients after resection was 32.7%. The MST for 52 non-surgical patient received VEMT regimen was 8 M, but MST for the recent 15 patients received CAV or COMP regimens is prolonged by 17 M. On the treatment for non-small cell lung cancer, our recent study shows a significant improvement in response rates for patients on platinum-containing combination chemotherapy. CAP regimen produces a longer MST in patients with adenocarcinoma or large cell carcinoma compared with MFC regimen (13 M vs 9 M).
D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D011013:Pneumonectomy / Q000401:mortality
D001500:BCG Vaccine